Hydreight Technologies Inc. (NURS.V) Deep Dive Video
Summary
Hydreight’s 449% Q1 growth, 50-state compliance moat, and CAD 15.52 base-case target create substantial upside, balanced by peptide-regulation and license-onboarding risks.
View NURS.V stock page · Read the NURS.V research report
Loading the video player…